[
  {
    "ts": null,
    "headline": "Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects",
    "summary": "Many investors continue to be worried about Incyte’s financial prospects when the patent for the company’s blood cancer medication, Jakafi, expires in 2028. We believe the company is preparing well for the post-expiry period and is on a growth path irrespective of the financial impact of patent expiry. Incyte Corporation (INCY) is a biopharmaceutical company […]",
    "url": "https://finnhub.io/api/news?id=a1c99efcac82cc6052f9a07987a0042def9e81cbcf43858c3b07389c3504dd5d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731769563,
      "headline": "Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects",
      "id": 131398920,
      "image": "https://s.yimg.com/ny/api/res/1.2/nUb.EatUcdHMc8M4ji9mqw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/2c6af9abc0ed048a4d4e97d83ed9c5c8",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Many investors continue to be worried about Incyte’s financial prospects when the patent for the company’s blood cancer medication, Jakafi, expires in 2028. We believe the company is preparing well for the post-expiry period and is on a growth path irrespective of the financial impact of patent expiry. Incyte Corporation (INCY) is a biopharmaceutical company […]",
      "url": "https://finnhub.io/api/news?id=a1c99efcac82cc6052f9a07987a0042def9e81cbcf43858c3b07389c3504dd5d"
    }
  }
]